The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Mono Vaccine Market Research Report 2024

Global Mono Vaccine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1794697

No of Pages : 82

Ask Your Query

Synopsis

Mono vaccines reduce the number of shots your child needs while protecting against only one serious diseases

The global Mono Vaccine market was valued at US$ 14250 million in 2023 and is anticipated to reach US$ 20410 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Mono Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mono Vaccine.

Report Scope

The Mono Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mono Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mono Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • GSK
  • Sanofi Pasteur
  • Merck
  • Pfizer
  • CNBG
  • Sanofi Pasteur MSD
  • Serum Institute of India
  • Biokangtai

Segment by Type

  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Yellow Fever Vaccine
  • Hepatitis Vaccine
  • Cholera Vaccine
  • Other

Segment by Application

  • Adults
  • Children

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mono Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Mono Vaccine Market Overview
1.1 Product Overview and Scope of Mono Vaccine
1.2 Mono Vaccine Segment by Type
1.2.1 Global Mono Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Mono Vaccine Segment by Application
1.3.1 Global Mono Vaccine Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Mono Vaccine Market Size Estimates and Forecasts
1.4.1 Global Mono Vaccine Revenue 2019-2030
1.4.2 Global Mono Vaccine Sales 2019-2030
1.4.3 Global Mono Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mono Vaccine Market Competition by Manufacturers
2.1 Global Mono Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mono Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mono Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Mono Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mono Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mono Vaccine, Product Type & Application
2.7 Mono Vaccine Market Competitive Situation and Trends
2.7.1 Mono Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mono Vaccine Players Market Share by Revenue
2.7.3 Global Mono Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mono Vaccine Retrospective Market Scenario by Region
3.1 Global Mono Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mono Vaccine Global Mono Vaccine Sales by Region: 2019-2030
3.2.1 Global Mono Vaccine Sales by Region: 2019-2024
3.2.2 Global Mono Vaccine Sales by Region: 2025-2030
3.3 Global Mono Vaccine Global Mono Vaccine Revenue by Region: 2019-2030
3.3.1 Global Mono Vaccine Revenue by Region: 2019-2024
3.3.2 Global Mono Vaccine Revenue by Region: 2025-2030
3.4 North America Mono Vaccine Market Facts & Figures by Country
3.4.1 North America Mono Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mono Vaccine Sales by Country (2019-2030)
3.4.3 North America Mono Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Mono Vaccine Market Facts & Figures by Country
3.5.1 Europe Mono Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mono Vaccine Sales by Country (2019-2030)
3.5.3 Europe Mono Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mono Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Mono Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mono Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Mono Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mono Vaccine Market Facts & Figures by Country
3.7.1 Latin America Mono Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mono Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Mono Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mono Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mono Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mono Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mono Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mono Vaccine Sales by Type (2019-2030)
4.1.1 Global Mono Vaccine Sales by Type (2019-2024)
4.1.2 Global Mono Vaccine Sales by Type (2025-2030)
4.1.3 Global Mono Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Mono Vaccine Revenue by Type (2019-2030)
4.2.1 Global Mono Vaccine Revenue by Type (2019-2024)
4.2.2 Global Mono Vaccine Revenue by Type (2025-2030)
4.2.3 Global Mono Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Mono Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mono Vaccine Sales by Application (2019-2030)
5.1.1 Global Mono Vaccine Sales by Application (2019-2024)
5.1.2 Global Mono Vaccine Sales by Application (2025-2030)
5.1.3 Global Mono Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Mono Vaccine Revenue by Application (2019-2030)
5.2.1 Global Mono Vaccine Revenue by Application (2019-2024)
5.2.2 Global Mono Vaccine Revenue by Application (2025-2030)
5.2.3 Global Mono Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Mono Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Mono Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Mono Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Mono Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Mono Vaccine Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CNBG Mono Vaccine Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Sanofi Pasteur MSD
6.6.1 Sanofi Pasteur MSD Corporation Information
6.6.2 Sanofi Pasteur MSD Description and Business Overview
6.6.3 Sanofi Pasteur MSD Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Pasteur MSD Mono Vaccine Product Portfolio
6.6.5 Sanofi Pasteur MSD Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Mono Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Biokangtai
6.8.1 Biokangtai Corporation Information
6.8.2 Biokangtai Description and Business Overview
6.8.3 Biokangtai Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biokangtai Mono Vaccine Product Portfolio
6.8.5 Biokangtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mono Vaccine Industry Chain Analysis
7.2 Mono Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mono Vaccine Production Mode & Process
7.4 Mono Vaccine Sales and Marketing
7.4.1 Mono Vaccine Sales Channels
7.4.2 Mono Vaccine Distributors
7.5 Mono Vaccine Customers
8 Mono Vaccine Market Dynamics
8.1 Mono Vaccine Industry Trends
8.2 Mono Vaccine Market Drivers
8.3 Mono Vaccine Market Challenges
8.4 Mono Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock